Press Release: Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025

Dow Jones

23 Jan

Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025

SKILLMAN, N.J.--(BUSINESS WIRE)--January 23, 2025--

Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025.

The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event.

About Kenvue

Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno$(R)$ , BAND-AID(R) Brand, Johnson's(R) , Listerine(R) , Neutrogena(R) and Tylenol(R) , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/

 
    CONTACT:    Investor Relations:

Sofya Tsinis

Kenvue_IR@Kenvue.com

Media Relations:

Melissa Witt

Media@Kenvue.com

(END) Dow Jones Newswires

January 23, 2025 06:47 ET (11:47 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2505099078"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2505099078\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2505099078?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-23 19:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2505099078","market":"hk","top_or_hot":-1,"title":"Press Release: Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 \n</p>\n<pre>\nSKILLMAN, N.J.--(BUSINESS WIRE)--January 23, 2025-- \n</pre>\n<p>\n     <a href=\"https://laohu8.com/S/KVUE\">Kenvue Inc</a>. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. \n</p>\n<p>\n     The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event. \n</p>\n<p>\n     About Kenvue \n</p>\n<p>\n     Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno<a href=\"https://laohu8.com/S/R\">$(R)$</a> , BAND-AID(R) Brand, Johnson's(R) , Listerine(R) , Neutrogena(R) and Tylenol(R) , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com. \n</p>\n<p>\n     View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/ \n</p>\n<pre>\n \n    CONTACT:    Investor Relations: \n</pre>\n<p>\n     Sofya Tsinis \n</p>\n<p>\n     Kenvue_IR@Kenvue.com \n</p>\n<p>\n     Media Relations: \n</p>\n<p>\n     Melissa Witt \n</p>\n<p>\n     Media@Kenvue.com \n</p>\n<pre>\n \n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 23, 2025 06:47 ET (11:47 GMT)\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Press Release: Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPress Release: Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-23 19:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 \n</p>\n<pre>\nSKILLMAN, N.J.--(BUSINESS WIRE)--January 23, 2025-- \n</pre>\n<p>\n     <a href=\"https://laohu8.com/S/KVUE\">Kenvue Inc</a>. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. \n</p>\n<p>\n     The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event. \n</p>\n<p>\n     About Kenvue \n</p>\n<p>\n     Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno<a href=\"https://laohu8.com/S/R\">$(R)$</a> , BAND-AID(R) Brand, Johnson's(R) , Listerine(R) , Neutrogena(R) and Tylenol(R) , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com. \n</p>\n<p>\n     View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/ \n</p>\n<pre>\n \n    CONTACT:    Investor Relations: \n</pre>\n<p>\n     Sofya Tsinis \n</p>\n<p>\n     Kenvue_IR@Kenvue.com \n</p>\n<p>\n     Media Relations: \n</p>\n<p>\n     Melissa Witt \n</p>\n<p>\n     Media@Kenvue.com \n</p>\n<pre>\n \n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 23, 2025 06:47 ET (11:47 GMT)\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B3T34201.USD","symbol_name":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2505099078","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2505099078","pubTimestamp":1737632820,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Kenvue Inc.  will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025.Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno , BAND-AID Brand, Johnson's , Listerine , Neutrogena and Tylenol , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4588":"碎股","R":"瑞德系统","BK4232":"货物陆运","BK4183":"个人用品","BK4022":"陆运","KVUE":"Kenvue Inc","BK4585":"ETF&股票定投概念"},"translate_title":"新闻稿：Kenvue将于2025年2月6日公布2024年第四季度和全年业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KVUE":0.9,"R":1},"content_text":"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 \n\n\nSKILLMAN, N.J.--(BUSINESS WIRE)--January 23, 2025-- \n\n\nKenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. \n\n\n     The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event. \n\n\n     About Kenvue \n\n\n     Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno$(R)$ , BAND-AID(R) Brand, Johnson's(R) , Listerine(R) , Neutrogena(R) and Tylenol(R) , are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com. \n\n\n     View source version on businesswire.com: https://www.businesswire.com/news/home/20250123211823/en/ \n\n\n \n    CONTACT:    Investor Relations: \n\n\n     Sofya Tsinis \n\n\n     Kenvue_IR@Kenvue.com \n\n\n     Media Relations: \n\n\n     Melissa Witt \n\n\n     Media@Kenvue.com \n\n\n \n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 23, 2025 06:47 ET (11:47 GMT)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}